XML 21 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations and Comprehensive Income (Loss) (Parenthetical) - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2019
Total net revenue $ 396,289 $ 382,928 $ 418,785
Total cost of revenue [1] 236,782 233,207 256,134
Products      
Total net revenue [2] 176,647 167,302 196,665
Total cost of revenue 102,100 95,882 116,711
Services      
Total net revenue [3] 219,642 215,626 222,120
Total cost of revenue 134,682 137,325 139,423
Revenue from Joint Venture      
Total cost of revenue 13,310 13,174 0
Revenue from Joint Venture | Products      
Total net revenue 12,033 11,202 0
Revenue from Joint Venture | Services      
Total net revenue $ 12,360 $ 7,851 $ 0
[1]

Includes cost of revenue from sales to the China joint venture, an equity method investment of $13,310 for the year ended June 30, 2021, $13,174 for the years ended June 30, 2020 and $0 for the year ended June 30, 2019, respectively. See Note 13.

[2] Includes sales to the China joint venture, an equity method investment of $12,033 for the year ended June 30, 2021, $11,202 for the years ended June 30, 2020 and $0 for the year ended June 30, 2019, respectively. See Note 13.
[3]

Includes sales to the China joint venture, an equity method investment of $12,360 for the year ended June 30, 2021, $7,851 for the years ended June 30, 2020 and $0 for the year ended June 30, 2019, respectively. See Note 13.